8-エピヘレナリンは,STAT3/FAKシグナリング軸を調節することによって,腫瘍発生と転移を抑制する

Fan Nie¹, Haojing Jiang¹, Ruyu Cao¹

¹State Key Laboratory of Medicinal Chemistry Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China.

European journal of pharmacology

|August 30, 2025

まとめ

8-エピヘレナリンという天然化合物は,肝細胞癌 (HCC) に対して強い抗がん効果を示しています. 複数の経路をターゲットにすることで腫瘍の成長,転移,血管新生を抑制します

科学分野:

自然製品化学
腫瘍学
薬理学について

背景:

肝細胞癌 (HCC) は,世界的な健康問題です.
新しい抗癌薬の発見には自然製品が不可欠です

研究の目的:

イヌラ・ジャポニカから8エピヘレナリンを分離し,特徴づけること.
8-エピヘレナリンのHCCに対する in vitroおよびin vivoの抗がん性を評価する.
抗腫瘍作用の分子メカニズムを解明する

主な方法:

イヌラ・ジャポニカから8-エピヘレナリンを分離した.
人間のHCC細胞系 (HepG2) を用いたインビトロ抗増殖試験
ゼブラフィッシュの異種移植モデルを用いた in vivo 効果評価
アポトーシス,細胞移動,フェロプトーシス,血管新生経路を含むメカニズム研究.

主要な成果:

8エピヘレナリンはHCC細胞に対する強力な抗増殖作用を示した.
腫瘍の成長と転移抑制を in vivo 試験で確認した.
メカニズムはアポトーシス誘導 (STAT3経路),移住抑制 (FAK経路),フェロプトーシス誘発 (脂質ROS,GSH),および抑制された血管新生を含む.

結論:

8 - エピヘレナリンは,HCCに対する多標的抗がん作用を示す.
多様な分子経路でHCCの進行を効果的に阻害する.
8エピヘレナリンは,HCC治療の治療候補として有望である.

キーワード:

血管新生アポトーシスセスキーターペンゼブラフィッシュフェロプトーシス

さらに関連する動画

06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.3K

06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.3K

関連する概念動画

02:38

Mitogens and the Cell Cycle

6.6K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

6.6K

01:15

Drugs that Stabilize Microtubules

2.1K

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

2.1K

01:22

PI3K/mTOR/AKT Signaling Pathway

3.9K

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

3.9K

01:19

Interactions Between Signaling Pathways

6.4K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

6.4K

01:24

Regulation of Angiogenesis and Blood Supply

2.7K

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

2.7K

01:20

The JAK-STAT Signaling Pathway

9.2K

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...